Cargando…

Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer

Aberrant DNA methylation is widely observed in many cancers. Concurrent DNA methylation of multiple genes occurs in endometrial cancer and is referred to as the CpG island methylator phenotype (CIMP). However, the features and causes of CIMP-positive endometrial cancer are not well understood. To in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanokura, Megumi, Banno, Kouji, Adachi, Masataka, Aoki, Daisuke, Abe, Kuniya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435325/ https://www.ncbi.nlm.nih.gov/pubmed/28440489 http://dx.doi.org/10.3892/ijo.2017.3966

Ejemplares similares

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)

Mutations of RAS genes in endometrial polyps
por: Takeda, Takashi, et al.
Publicado: (2019)

MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
por: Yanokura, Megumi, et al.
Publicado: (2020)

Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
por: BANNO, KOUJI, et al.
Publicado: (2012)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013)

New use of microsatellite instability analysis in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2017)

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015)

New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013)

Endometrial Cancer as a Familial Tumor: Pathology and Molecular Carcinogenesis (Review)
por: Banno, Kouji, et al.
Publicado: (2009)

MicroRNAS in endometrial cancer: recent advances and potential clinical applications
por: Yanokura, Megumi, et al.
Publicado: (2015)

Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report
por: Takeda, Takashi, et al.
Publicado: (2018)

ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012)

Current status of uterine regenerative medicine for absolute uterine factor infertility
por: Matoba, Yusuke, et al.
Publicado: (2019)

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
por: Masuda, Kenta, et al.
Publicado: (2011)

Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013)

Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
por: Takeda, Takashi, et al.
Publicado: (2018)

Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
por: Banno, Kouji, et al.
Publicado: (2014)

Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)
por: BANNO, KOUJI, et al.
Publicado: (2013)

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015)

Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors
por: Hirasawa, Akira, et al.
Publicado: (2013)

18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
por: Ogino, Shuji, et al.
Publicado: (2007)

LncRNA miR663AHG represses the development of colon cancer in a miR663a-dependent manner
por: Yuan, Hongfan, et al.
Publicado: (2023)

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome
por: Masuda, Kenta, et al.
Publicado: (2011)

Indocyanine Green Fluorescence Imaging for Evaluation of Uterine Blood Flow in Cynomolgus Macaque
por: Kisu, Iori, et al.
Publicado: (2012)

Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers
por: Chong, Allen, et al.
Publicado: (2016)

Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology
por: Nogami, Yuya, et al.
Publicado: (2019)

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation
por: MASUDA, KENTA, et al.
Publicado: (2012)

Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
por: MASUDA, KENTA, et al.
Publicado: (2012)

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis
por: Datta, Indrani, et al.
Publicado: (2021)

The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2019)

Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’
por: Tapial, Sandra, et al.
Publicado: (2018)

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer
por: McInnes, Tyler, et al.
Publicado: (2017)

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018)

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”
por: Bae, Jeong Mo, et al.
Publicado: (2018)

Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019)

Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas
por: Li, Jie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4rbkt7kfu906sj50voobim5761